Dear Colleagues,
Tobacco remains the leading preventable cause of death in the United States, and disproportionately affects people with mental illness. E-cigarette use is increasing in the United States and people with mental illness are reporting use that is greater than the general population.
Psychiatrists are being faced with questions about use and risks regularly or are often unsure what to recommend to patients. This webinar will summarize tobacco use among those with mental illness, discuss e-cigarettes, and summarize the most recent recommendations on risks and safety. We will also discuss tobacco cessation as well as offer concrete resources and recommendations to viewers.
Educational Objectives
- Cite the epidemiology regarding smokers with mental illness
- Describe e-cigarette use patterns in those with mental illness and in general
- Summarize the evidence based methods of treating tobacco use disorders including 7 FDA approved medications and common psychosocial approaches including the 5 As
- Identify where to access resources on smoking cessation education for use later
- Review the most up to date data on recommendations on e-cigarettes use
Please select below to register for this webinar
June 21, 2017 @ 12:00 pm – 1:00 pm ET
Accreditation and Designation
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.